Eligible participant has to fullfill all of the following items | / / / / / / / |
Anyone with one of following items or more should be excluded: | / / / / / / / / / / |
- General information
- Medical history
- Physical examination
- Blood Routine Tests
- Urine Routine Test
- Blood Electrolytes Tests
- Coagulation Function Tests
- Serum Liver Function Tests
- HBV/HCV/HIV/Syphilis Markers Test
- Renel Function Test
- D-dimer
- hCG Test
- Image Examinations
- Visual Analogue Scale
- Blood Gas Analysis
Date of signing the informed consent | 2024-3-14 |
Date of birth | 2006-7-10 yyyy-mm-dd |
Age | 17 Years |
Education background | Middle school
|
Occupation | Other
|
Other (Description) | 学生 |
12 小时 |
|
午睡后 |
|
Number of pregnancy | 0 次 |
Number of delivery | - 次 |
If has delivery history, select following items | |
partus maturus | - 次 |
premature delivery | - 次 |
abortion | - 次 |
Last pregnancy | - yyyy-mm-dd |
Average times of menstrual onset a year | 9.8 次/年 |
Average menstrual cycle | 6.5 天(days) |
Menarche time | 14 岁(years) |
The time of last Menstruation | 2024-2-1 年、月、日(yyyy-mm-dd) |
The time of menstrual onset before the last one | 不详 年、月、日(yyyy-mm-dd) |
-- |
|
-- 年/月/日(yyyy-mm-dd) |
|
Namy of the drug to be allergied | -- |
Vulva | Normal
|
Description in detail for abnormal | -- |
Vagina | Not examined
|
Description in detail for abnormal | -- |
Uterine neck | Not examined
|
Description in detail for abnormal | -- |
Corpus uteri | Not examined
|
Description in detail for abnormal | -- |
Adnexa uteri | |
Left side | Not examined
|
Description in detail for abnormal | -- |
Right side | Not examined
|
Description in detail for abnormal | -- |
Weight | 55 kg |
Hight | 1500 mm |
Systolic pressure (SP) | 89 mmHg |
Diastolic pressure | 78 mmHg |
Temperature | 36.2 degree Celsius |
Pulse rate | 72 次/分 |
Breath frequency | 18 次/分 |
Doctor signature | 刘义彬 |
Date | 2024-3-14 yyyy-mm-dd |
WBC | 13.30 ×109 /L |
NEUT% | 88.09 % |
LY% | 7.77 % |
RBC | 2.97 ×10^12 /L |
MONO% | 3.93 % |
HGB | 98 g/L |
PLT | 239 ×10^9 /L |
Researcher signature | 刘义彬 |
Date | 2024-3-14 yyyy-mm-dd |
Acidity and allkalinity | |
pH value | 未查 |
Urine protein | |
Urine red cell | |
Urine WBC | |
Urine glucos | |
Urine Bilirubin | |
Urine HCG | |
KET | |
SG | 未查 |
UBG | |
NIT | |
Date of test | 未查 yyyy-mm-dd |
Date of test | 2024-3-14 yyyy-mm-dd |
K | 4.20 mmol/L |
Na | 141.0 mmol/L |
Cl | 102.3 mmol/L |
Ca | 2.47 mmol/L |
P | 1.02 mmol/L |
Date of examination | 2024-3-14 yyyy-mm-dd |
Prothrombin time | 12.2 秒 |
Thrombin time (TT) | 17.8 秒 |
Activated partial thromboplastin time (APTT) | 30.4 秒 |
Fibrinogen (FIB) | 1.92 g/L |
ALT | 26.3 IU/L |
AST | 42.5 IU/L |
GGT | 26.0 U/L |
Serum bilirubin | 12.70 μmol/L |
Indirect bilirubin | 11.40 umol/L |
Direct bilirubin | 1.30 umol/L |
Serum albumin | 49.3 g/L |
Serum globulin | 29.6 g/L |
Serum total protein | 78.9 g/L |
Date of test | 2024-3-14 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-3-14 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-3-14 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-3-14 yyyy-mm-dd |
Negative
|
|
Date of test | 2024-3-14 yyyy-mm-dd |
SCr | 67 μmol/L |
Blood urea | 4.40 mmol/L |
Blood uric acid | 302.0 μmol/L |
Date of test | 2024-3-14 yyyy-mm-dd |
D-dimer value | 0.12 ug/mL |
Date of test | 2024-3-14 |
Urine pregnancy test | Not tested
|
Blood HCG concentration | 未查 mIU/mL |
Date of test | -- yyyy-mm-dd |
Size of the ulcer | 5.3*5.2*4.2 cm*cm |
Uterine echo distribution | Even
|
Endometrial thickness | 1.2 mm |
Left ovary size | 报告不清 cm ×cm |
Shape of Left ovary | |
Size of the Ovarian cyst | 子宫前方18㎝囊性肿物 |
Right ovary size | -- cm ×cm |
Shape of right ovary | |
Size of Ovarian cyst | -- |
Description of other abnormal findings | -- |
Diagnosis of the Ultrasound B | 卵巢囊肿蒂扭转 |
Doctor signature | 刘义彬 |
Date of examination | 2024-3-14 yyyy-mm-dd |
Pain Visual Analogue Score | Very pain
|
P02 | mmHg |
SO2 | % |
SBE | mmol/l |
HCO3 | mmol/l |
Date of examination | 未查 (yyyy-mm-dd) |
LAC | mmol/L |
PCO2 | mmHg |
PH | 未查 |
右卵巢 |
|
18*18 cm |
|
5周 ° |
|
/ | |
刘义彬 |
|
2024-3-14 |
D-dimer value | 0.10 ug/mL |
Date of test | 2024-3-15 |
Body temperature | 37 ℃ |
Systolic pressure (SP) | -- mmHg |
Diastolic pressure (DP) | -- mmHg |
Heart Rate, HR | 100 次/分 |
Pulse | 100 次/秒 |
WBC | 9.94 ×109 /L |
NEUT% | 76.50 % |
LY% | 16.60 % |
MONO% | 5.50 % |
RBC | 2.56 ×10^12 /L |
HGB | 82 g/L |
PLT | 219 ×10^9 /L |
Date | 2024-3-15 yyyy-mm-dd |
/ | |
Pain Visual Analogue Score | Occasionally very slight pain
|
sample collection | Collected
|
Volume | 2 ml |
Time of collection | 2024-3-14 -15 yyyy-mm-dd-hh-min. |
Label Number of the sample | 2573853 |
Date received at DCC | -- yyyymmdd |
Report type | |
Name of this event | -- |
SAE start date | -- yyyymmdd |
SAE stop date | -- yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below |
|
Name of the recorder |
|
Data | yyyymmdd |
Site Investigator’s signature | 刘义彬 |
Data | 2024-3-15 yyyymmdd |